Hatteras Venture Advisors III, LLC → Clearside Biomedical, Inc. CLSDQ

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (18.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 18.07

95,698 shares short · 0.0% vs prior

Other 13D/G Filings on Clearside Biomedical, Inc.

Filed	Form	Filer	Stake	Shares
2025-02-21	SCHEDULE	Hatteras Venture Advisors IV SBIC, LLC	40.00%	313,641	view →
2019-12-04	SC	Hatteras Venture Advisors III, LLC	—	—	view →

Other Filings by Hatteras Venture Advisors III, LLC

Filed	Form	Issuer	Stake	Shares
2019-12-04	SC	Clearside Biomedical, Inc. CLSDQ	—	—	view →
2019-07-29	SC	PhaseBio Pharmaceuticals Inc	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →